CJC-1295 and Ipamorelin Dosage Calculator: What Online Tools Can and Cannot Tell You

An online CJC-1295/ipamorelin calculator can convert vial strength, reconstitution volume, and a target amount into mL or U-100 syringe units. It cannot tell you a safe personal dose. CJC-1295 and ipamorelin are not FDA-approved medicines, and dosing should come only from a licensed clinician or pharmacy instructions.

What does a CJC-1295/ipamorelin dosage calculator actually calculate?

A CJC-1295/ipamorelin calculator calculates liquid math. It uses the vial amount, the amount of bacteriostatic water added, a target amount, and the syringe type to estimate concentration, draw volume, and U-100 units 1.

That math can be useful for checking arithmetic. It is not the same as choosing a medical dose, deciding whether a peptide is appropriate, or replacing pharmacy directions.

Calculator inputs: vial amount, diluent volume, target amount, syringe type

• Vial amount: the total peptide listed on the vial, usually in milligrams.
• Diluent volume: the amount of bacteriostatic water added during reconstitution, in milliliters.
• Target amount: the amount being modeled, usually in micrograms.
• Syringe type: most online examples use a U-100 insulin syringe, where 100 units equals 1 mL 2.

Calculator outputs: concentration, draw volume, and U-100 units

Most peptide calculators first convert the vial to micrograms, then divide by the water volume to get concentration. Then they divide the target amount by that concentration to get mL, and multiply mL by 100 to show U-100 syringe units 1.

Why calculator math is not the same as a medical dose

A calculator cannot review your lab work, pituitary history, glucose control, cancer history, pregnancy status, or medication list. It also cannot confirm sterility, vial identity, pharmacy directions, or whether the peptide should be used at all.

Quick facts

U-100 syringe math is simple, but peptide labels are not always simple. The most important number is 100 units = 1 mL, which means the unit mark depends on concentration, not just dose 2.

• 100 U-100 units equals 1 mL on a U-100 insulin syringe 2.
• 1 mg equals 1,000 mcg; this conversion should happen before mcg-based calculations 1.
• Changing bacteriostatic water volume changes concentration and the volume needed for the same target amount 1.
• Blend labels can mean total peptide or separate peptide amounts, so the vial label and pharmacy instructions matter 3.
• CJC-1295 with DAC and CJC-1295 no DAC are not interchangeable because the DAC form was designed for longer exposure 4.

How do you calculate CJC-1295/ipamorelin units step by step?

The calculation has 4 steps: confirm the label, convert mg to mcg, calculate mcg per mL, then convert mL to U-100 units. This is math only; it does not select a dose.

1. 1Confirm what is on the vial label. A blend vial should state whether the amount is total peptide or the amount of each component.
2. 2Convert milligrams to micrograms. For example, 10 mg equals 10,000 mcg.
3. 3Calculate concentration. Divide total mcg in the vial by total mL of bacteriostatic water.
4. 4Convert the modeled mL to U-100 units. On a U-100 syringe, mL × 100 = units 2.

Worked math example using a hypothetical 10 mg total blend vial

In a hypothetical math example, a vial labeled 10 mg total blend contains 10,000 mcg total peptide. If it is reconstituted with 2 mL bacteriostatic water, the concentration is 10,000 mcg ÷ 2 mL = 5,000 mcg/mL 1.

If a clinician or pharmacy direction gave a target amount of 250 mcg for that specific vial, the math would be 250 mcg ÷ 5,000 mcg/mL = 0.05 mL. On a U-100 syringe, 0.05 mL × 100 = 5 units. This is a calculation example, not a dosing recommendation.

Why do blend vials cause dosing mistakes?

Blend vials can cause mistakes because the label may describe the total amount in the vial or the amount of each peptide. A 10 mg vial could mean 10 mg total blend, or it could be described elsewhere as separate component amounts, so the label and pharmacy instructions must match the calculation 3.

A 1:1 blend means the two peptides are present in equal amounts. Other ratios are possible. If the clinical direction is component-specific, the calculation is incomplete until you know how much CJC-1295 and how much ipamorelin are present.

What is the difference between CJC-1295 with DAC, CJC-1295 no DAC, and ipamorelin?

CJC-1295 no DAC, CJC-1295 with DAC, and ipamorelin are different compounds. Their mechanisms all involve growth hormone signaling, but they are not interchangeable in calculator setup or clinical decision-making.

CJC-1295 no DAC, also called modified GRF 1-29 in some sources

CJC-1295 no DAC is often discussed as a growth hormone-releasing hormone analog, and modified GRF 1-29 is a related term used in some peptide sources. It is intended to act through the pituitary gland’s growth hormone-releasing hormone pathway, which is different from a ghrelin-like secretagogue pathway 4.

CJC-1295 with DAC and longer exposure

The DAC form was designed to bind albumin and extend exposure. In a human study, CJC-1295 increased growth hormone and IGF-1 exposure for days after a single injection, which is why with-DAC and no-DAC forms should not be treated as the same input 4.

Ipamorelin as a growth hormone secretagogue

Ipamorelin is a growth hormone secretagogue and ghrelin receptor agonist that has been studied for its ability to stimulate growth hormone release. Early studies described selective growth hormone release compared with some older secretagogues, but that does not prove anti-aging, fat-loss, or lifespan benefit in humans 5.

Why mechanism differences affect clinical decisions, not just calculator math

Growth hormone and IGF-1 affect fluid balance, glucose metabolism, soft tissue, and endocrine feedback. For that reason, mechanism differences should be reviewed by a clinician, not handled as a simple spreadsheet problem 6.

Are there validated human doses for CJC-1295/ipamorelin?

No FDA-approved brand name exists for CJC-1295 or ipamorelin, and there is no FDA-labeled human dosing regimen for the CJC-1295/ipamorelin blend. Online wellness ranges should not be treated as validated dosing.

A phase 1 human study of CJC-1295 evaluated single subcutaneous doses and repeated dosing schedules in healthy adults, and reported increases in growth hormone and IGF-1 exposure 4. That kind of pharmacology study can show biologic activity, but it does not establish a validated longevity, sleep, recovery, body-composition, or wellness protocol.

Ipamorelin has also been studied as a growth hormone secretagogue, but the available evidence should not be turned into claims of proven anti-aging or body-composition outcomes 5. Children, pregnancy, cancer history, diabetes, pituitary disorders, endocrine disease, and interacting medicines all call for medical review before any peptide plan is considered 6.

What safety issues should patients understand before using peptide calculators?

Peptide calculator safety starts with knowing that arithmetic is only one risk. Sterility, vial identity, injection technique, endocrine effects, and follow-up monitoring all matter.

Subcutaneous injection can cause injection-site pain, redness, swelling, or infection risk if sterile technique is poor. USP sterile compounding standards focus on reducing contamination risk during sterile preparation, which is one reason licensed pharmacy sourcing matters 7.

Growth hormone and IGF-1 biology can affect glucose, fluid retention, joint symptoms, soft tissue swelling, and sleep-related breathing issues in susceptible patients. Endocrine guidelines for growth hormone excess highlight the need to assess glucose, cardiovascular risk, sleep apnea, and related complications when GH/IGF-1 signaling is abnormal 6.

Grey-market peptide vials add extra risk because the product may not come from a state-licensed 503A pharmacy, may not match the label, and may not be prepared under sterile pharmacy standards. The FDA warns that compounded drugs are not FDA-approved and that quality depends on appropriate compounding practices and oversight 8. For more detail, see our guide to peptides online and our article on peptide side effects.

Does Chia offer CJC-1295 or ipamorelin online?

Chia does not currently list CJC-1295 or ipamorelin as available treatments. We do offer clinician-reviewed access to certain other peptide and longevity options, including sermorelin, NAD+, glutathione, and the Foundation Longevity protocol, when clinically appropriate.

Sermorelin is a different peptide from CJC-1295/ipamorelin. It is a growth hormone-releasing hormone analog that has been studied in children with growth hormone deficiency and in adult research settings, but it should not be assumed to have the same profile as CJC-1295 or ipamorelin 9.

At Chia, treatment starts with a short online health questionnaire. A licensed US provider reviews eligibility and prescribes only when clinically appropriate; a prescription is never guaranteed. When Chia prescribes eligible compounded treatments, they are made in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Compounded medications are not FDA-approved.

If your real question is whether a growth-hormone-axis peptide makes sense for your goals, our guide to CJC-1295 and ipamorelin prescription online and our comparison of CJC-1295/ipamorelin vs sermorelin can help you understand the differences before you talk with a clinician.

When should you avoid using an online calculator and ask a clinician instead?

Ask a clinician instead of relying on a calculator when the question is medical, not mathematical. That includes unclear labels, mismatched instructions, health conditions, pregnancy, medication interactions, or any attempt to choose a dose.

• The vial label is unclear, missing, or does not match the pharmacy instructions.
• The calculator result does not match what the pharmacy or prescriber provided.
• The vial is a blend and you cannot confirm whether the label means total peptide or separate component amounts.
• You have diabetes, abnormal glucose, pituitary disease, endocrine conditions, sleep apnea, swelling, cancer history, or pregnancy-related concerns 6.
• You are trying to decide whether to use CJC-1295, ipamorelin, sermorelin, or another peptide rather than checking arithmetic.

Keep reading

Peptides

CJC-1295 Side Effects: Common, Serious, and Long-Term Risks

Longevity Peptides

CJC-1295 Peptide: How It Works, Benefits, Risks, and Legal Status

Peptides

CJC Peptide (CJC-1295): What It Is, How It Works, and What the Evidence Shows